Novel Transplant and Post-Transplant Options in ALL

被引：0
作者：
Logan, Aaron C. [1 ]
机构：
[1] Univ Calif San Francisco, 505 Parnassus Ave,Box 1270, San Francisco, CA 94143 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
ALL; acute lymphoblastic leukemia; allogeneic hematopoietic cell transplant; measurable residual disease; blinatumomab; ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; CORD-BLOOD TRANSPLANTATION; LONG-TERM; HIGH-RISK; ADULT; BLINATUMOMAB; THERAPY; RELAPSE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXABS-104-
引用
收藏
页码：S7 / S9
页数：3
相关论文
共 20 条
  • [1] Akabane H, 2020, CLIN ADV HEMATOL ONC, V18, P413
  • [2] Unrelated Cord Blood Transplantation in Adult and Pediatric Acute Lymphoblastic Leukemia: Effect of Minimal Residual Disease on Relapse and Survival
    Bachanova, Veronika
    Burke, Michael J.
    Yohe, Sophia
    Cao, Qing
    Sandhu, Karamjeet
    Singleton, Timothy P.
    Brunstein, Claudio G.
    Wagner, John E.
    Verneris, Michael R.
    Weisdorf, Daniel J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) : 963 - 968
  • [3] Impact of detectable measurable residual disease on umbilical cord blood transplantation
    Baron, Frederic
    Labopin, Myriam
    Ruggeri, Annalisa
    Sierra, Jorge
    Robinson, Stephen
    Labussiere-Wallet, Helene
    Potter, Michael
    Ribera, Josep-Maria
    Deconinck, Eric
    Rambaldi, Alessandro
    Rohrlich, Pierre-Simon
    de Revel, Thierry
    Gluckman, Eliane
    Nagler, Arnon
    Mohty, Mohamad
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) : 1057 - 1065
  • [4] Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia AMeta-analysis
    Berry, Donald A.
    Zhou, Shouhao
    Higley, Howard
    Mukundan, Lata
    Fu, Shuangshuang
    Reaman, Gregory H.
    Wood, Brent L.
    Kelloff, Gary J.
    Jessup, J. Milburn
    Radich, Jerald P.
    [J]. JAMA ONCOLOGY, 2017, 3 (07)
  • [5] Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment
    Demosthenous, Christos
    Lalayanni, Chrysavgi
    Iskas, Michalis
    Douka, Vassiliki
    Pastelli, Nikoleta
    Anagnostopoulos, Achilles
    [J]. CURRENT PROBLEMS IN CANCER, 2019, 43 (03) : 222 - 227
  • [6] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    [J]. BLOOD, 2018, 131 (14) : 1522 - 1531
  • [7] HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
    Gooptu, Mahasweta
    Romee, Rizwan
    St Martin, Andrew
    Arora, Mukta
    Al Malki, Monzr
    Antin, Joseph H.
    Bredeson, Christopher N.
    Brunstein, Claudio G.
    Chhabra, Saurabh
    Fuchs, Ephraim J.
    Ghosh, Nilanjan
    Grunwald, Michael R.
    Kanakry, Christopher G.
    Kekre, Natasha
    McGuirk, Jospeh P.
    McNiece, Ian K.
    Mehta, Rohtesh S.
    Mielcarek, Marco
    Milano, Fillipo
    Modi, Dipenkumar
    Reshef, Ran
    Solomon, Scott R.
    Schroeder, Mark A.
    Waller, Edmund K.
    Inamoto, Yoshiro
    Soiffer, Robert J.
    Eapen, Mary
    [J]. BLOOD, 2021, 138 (03) : 273 - 282
  • [8] Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
    Jabbour, Elias
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Pemmaraju, Naveen
    Wierda, William
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Cortes, Jorge
    Garris, Rebecca
    Khoury, Joseph D.
    Jorgensen, Jeffrey
    Jain, Nitin
    Alvarez, Joie
    O'Brien, Susan
    Kantarjian, Hagop
    [J]. LANCET HAEMATOLOGY, 2018, 5 (12): : E618 - E627
  • [9] Kebriaei P, 2020, BIOL BLOOD MARROW TR, V26, pS102
  • [10] Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long Term Study Results
    Kebriaei, Partow
    Bassett, Roland
    Lyons, Genevieve
    Valdez, Ben
    Ledesma, Celina
    Rondon, Gabriela
    Oran, Betul
    Ciurea, Stefan
    Alousi, Amin
    Popat, Uday
    Patel, Krina
    Ahmed, Sairah
    Olson, Amanda
    Bashir, Qaiser
    Shah, Nina
    Jones, Roy
    Marin, David
    Rezvani, Katayoun
    Nieto, Yago
    Khouri, Issa
    Qazilbash, Muzaffar
    Hosing, Chitra
    Shpall, Elizabeth
    Champlin, Richard E.
    Andersson, Borje S.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) : 285 - 292
12